Program: Start-ups Meet Pharma (Accelerator)
Program targets: company with a validated proof of concept, market validation and prototype that matches one of the challenges released by the pharma companies.
Challenges of 2022:
1. Digital solutions improving referral and diagnostic pathway for rare diseases (Takeda)
2. Early diagnosis and identification of risk for disease progression in Chronic Kidney patients (Boehringer Ingelheim RCV)
3. Innovative solutions for pain management (Sintetica)
4. Care coordination between primary care and specialty care for Atherosclerotic Cardiovascular Disease patients with elevated LDL-c levels (Novartis)
Opportunities: One-on-one access to your pharma sponsors, allowing you to develop relationships with key stakeholders and industry leaders – Takeda, Boehringer Ingelheim, Sintetica and Novartis.
Activities will take place: May-November 2021
Location of activities: Hybrid, with online sessions (May 2-6, June 7-17, July 4-8)) and live session (September).
Submission of applications: till 14-03-2022
More information: https://eithealth.eu/programmes/start-ups-meet-pharma/
Informational webinar on 9 March 2022 at 11:00 AM CET. Registration: